ENZON PHARMACEUTICALS
About Enzon
Technology Platforms
Research & Development
Marketed Products
Partnering
Newsroom
Investors
Careers
Contact Us


ENZON HEADER PIC
Home > Investors
Analyst Coverage Annual Reports Press Releases SEC Filings
Request Information Calendar of Events E-mail Alerts Stock Quote Stock Lookup Corporate Governance Contact Us
Email Alert Subscription
Print Print page     Email Email page

Step 1 of 3: Select Options

You may automatically receive Enzon Pharmaceuticals Inc. financial information by email. Please enter your preferences for email notifications below and click "Continue" to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here.

Press Releases
SEC Filings
  
  
  
Webcasts and Events
in advance of any event.
Stock Information
Send me a stock update at the end of the trading day.
Send me a stock update at the end of the week.
Alert me when the stock crosses the following price thresholds:
Current Stock Price is $8.910
    
Alert me when the stock changes more than % in one day.

Unsubscribe from Investor Relations email alerts.

Our email alerts provide automated opt-out methods as well as complete contact information.

 

 

 

Stock Information
(ENZN) NASD
Last Trade 8.910
Change(%) - 0.06
Volume 641,000
May 15, 2008 4:15 PM ET
New Product Release
Lab Look
Our four proprietary marketed brands are ABELCET®, ADAGEN®, DEPOCYT®, and ONCASPAR®. To learn more about our recent product releases CLICK HERE
Shareholder Tools
  • Briefcase Shareholder Briefcase
  • Printed Materials Printed Materials
  • Email Alerts Email Alerts
  • Download Center Download Library
  • Glossary Glossary
  • RSS RSS News Feeds

  • Search Investor Relations


Copyright © 2005-2007 Enzon Pharmaceuticals, Inc. All rights reserved.
Terms of Use
Privacy Information